Total Payments
$11,982
2024 Payments
$354.11
Companies
42
Transactions
351
Medicare Patients
10,029
Medicare Billing
$447,319
Payment Breakdown by Category
Food & Beverage$8,777 (73.3%)
Travel$2,650 (22.1%)
Education$432.69 (3.6%)
Other$121.92 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,777 | 335 | 73.3% |
| Travel and Lodging | $2,650 | 10 | 22.1% |
| Education | $432.69 | 5 | 3.6% |
| Grant | $121.92 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $4,427 | 45 | $0 (2019) |
| Abbott Laboratories | $1,077 | 20 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $774.19 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $627.01 | 17 | $0 (2023) |
| Boston Scientific Corporation | $537.26 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $493.30 | 29 | $0 (2022) |
| Amgen Inc. | $457.50 | 27 | $0 (2024) |
| ABIOMED | $403.39 | 6 | $0 (2018) |
| PFIZER INC. | $367.38 | 26 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $346.25 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $354.11 | 17 | Novartis Pharmaceuticals Corporation ($171.00) |
| 2023 | $642.21 | 25 | Novartis Pharmaceuticals Corporation ($166.88) |
| 2022 | $1,067 | 57 | Actelion Pharmaceuticals US, Inc. ($211.61) |
| 2021 | $1,333 | 77 | PFIZER INC. ($151.10) |
| 2020 | $829.01 | 45 | Amgen Inc. ($160.44) |
| 2019 | $1,777 | 59 | Medtronic Vascular, Inc. ($811.18) |
| 2018 | $2,147 | 31 | Abbott Laboratories ($550.01) |
| 2017 | $3,833 | 40 | Medtronic Vascular, Inc. ($3,172) |
All Payment Transactions
351 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Cardiology | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/05/2024 | Cardiac Dimensions, Inc. | — | Food and Beverage | In-kind items and services | $18.90 | General |
| 04/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Not Applicable | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/29/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $17.13 | General |
| Category: Medical Device | ||||||
| 03/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiology | ||||||
| 01/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology | ||||||
| 11/30/2023 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/28/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Genetic Disease | ||||||
| 11/15/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: DIABETES | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,330 | 3,579 | $377,719 | $121,083 |
| 2022 | 28 | 2,828 | 3,093 | $362,709 | $120,589 |
| 2021 | 28 | 1,807 | 2,232 | $279,343 | $98,045 |
| 2020 | 26 | 2,064 | 2,390 | $314,023 | $107,602 |
Total Patients
10,029
Total Services
11,294
Medicare Billing
$447,319
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 674 | 683 | $112,012 | $34,321 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 329 | $68,761 | $30,053 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $20,605 | $7,413 | 36.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 968 | 1,095 | $28,470 | $6,474 | 22.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 173 | 175 | $15,575 | $4,811 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 75 | $12,075 | $4,564 | 37.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 75 | 75 | $14,475 | $4,123 | 28.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 46 | 49 | $13,195 | $3,997 | 30.3% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 129 | 140 | $10,780 | $3,564 | 33.1% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Facility | 2023 | 54 | 54 | $12,150 | $3,497 | 28.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 219 | 219 | $10,950 | $3,311 | 30.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 30 | 30 | $13,980 | $2,347 | 16.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 17 | $7,633 | $2,141 | 28.0% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 121 | 124 | $6,200 | $1,948 | 31.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 22 | 22 | $5,214 | $1,934 | 37.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 136 | 136 | $4,488 | $1,396 | 31.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 39 | 39 | $3,432 | $1,096 | 31.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 95 | 103 | $5,356 | $1,008 | 18.8% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2023 | 21 | 21 | $2,709 | $839.28 | 31.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 35 | 35 | $2,030 | $671.65 | 33.1% |
| 75571 | Ct scan of heart with evaluation of blood vessel calcium | Facility | 2023 | 21 | 21 | $3,507 | $351.55 | 10.0% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Facility | 2023 | 20 | 20 | $1,100 | $338.96 | 30.8% |
| 93307 | Ultrasound of heart | Facility | 2023 | 11 | 11 | $1,089 | $335.90 | 30.8% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Facility | 2023 | 16 | 17 | $935.00 | $281.44 | 30.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 11 | 11 | $660.00 | $192.27 | 29.1% |
About Dr. Taraka Gadiraju, MD
Dr. Taraka Gadiraju, MD is a Cardiovascular Disease healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2011. The National Provider Identifier (NPI) number assigned to this provider is 1356621353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Taraka Gadiraju, MD has received a total of $11,982 in payments from pharmaceutical and medical device companies, with $354.11 received in 2024. These payments were reported across 351 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,777).
As a Medicare-enrolled provider, Gadiraju has provided services to 10,029 Medicare beneficiaries, totaling 11,294 services with total Medicare billing of $447,319. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Tulsa, OK
- Active Since 08/22/2011
- Last Updated 04/16/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1356621353
Products in Payments
- Resolute (Device) $1,741
- Endurant (Device) $1,653
- CoreValve Evolut (Device) $852.47
- ENTRESTO (Drug) $738.78
- XARELTO (Drug) $493.30
- Impella (Device) $403.39
- ELIQUIS (Drug) $356.60
- Corlanor (Drug) $282.70
- LifeVest (Device) $256.47
- Asahi Fielder coronary guide wire (Device) $240.87
- CROSSBOSS (Device) $239.62
- OPSUMIT (Drug) $217.55
- Repatha (Biological) $174.80
- JARDIANCE (Drug) $172.24
- Livalo (Drug) $171.22
- BRILINTA (Drug) $170.26
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $167.63
- HeartMate (Device) $166.35
- FARXIGA (Drug) $151.53
- Vascepa (Drug) $150.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tulsa
Dr. Matthew Comstock, D.o, D.O
Cardiovascular Disease — Payments: $78,837
Cardiovascular Disease $78,837
Neil Agrawal, M.d, M.D
Cardiovascular Disease — Payments: $40,882
Cardiovascular Disease $40,882
Dr. David Wilkett, Do, DO
Cardiovascular Disease — Payments: $29,992
Cardiovascular Disease $29,992
Daniel Wildes, D.o, D.O
Cardiovascular Disease — Payments: $27,269
Cardiovascular Disease $27,269
Thomas Kalapura, Md, MD
Cardiovascular Disease — Payments: $18,323
Cardiovascular Disease $18,323
Dr. Jawad Trad, D.o, D.O
Cardiovascular Disease — Payments: $18,167
Cardiovascular Disease $18,167